Patents by Inventor Kelly H. Tabor

Kelly H. Tabor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatocyte Growth Factor Receptor Antagonists and Uses Thereof
    Publication number: 20140056921
    Abstract: Hepatocyte growth factor (HGF) receptor antagonists are provided. The HGF receptor antagonists include HGF receptor antibodies and fragments thereof. The HGF receptor antagonists can be employed to block binding of HGF to HGF receptors or substantially inhibit HGF receptor activation. The HGF receptor antagonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treating cancer using the HGF receptor antagonists are also provided.
    Type: Application
    Filed: June 6, 2013
    Publication date: February 27, 2014
    Applicant: Genentech, Inc.
    Inventors: Ralph H. Schwall, Kelly H. Tabor
  • HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF
    Publication number: 20120321628
    Abstract: Hepatocyte growth factor (HGF) receptor antagonists are provided. The HGF receptor antagonists include HGF receptor antibodies and fragments thereof. The HGF receptor antagonists can be employed to block binding of HGF to HGF receptors or substantially inhibit HGF receptor activation. The HGF receptor antagonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treating cancer using the HGF receptor antagonists are also provided.
    Type: Application
    Filed: June 8, 2012
    Publication date: December 20, 2012
    Applicant: Genentech, Inc.
    Inventors: Ralph H. Schwall, Kelly H. Tabor
  • HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF
    Publication number: 20110280870
    Abstract: Hepatocyte growth factor (HGF) receptor antagonists are provided. The HGF receptor antagonists include HGF receptor antibodies and fragments thereof. The HGF receptor antagonists can be employed to block binding of HGF to HGF receptors or substantially inhibit HGF receptor activation. The HGF receptor antagonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treating cancer using the HGF receptor antagonists are also provided.
    Type: Application
    Filed: January 24, 2011
    Publication date: November 17, 2011
    Applicant: Genentech, Inc.
    Inventors: Ralph H. Schwall, Kelly H. Tabor
  • HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF
    Publication number: 20090148457
    Abstract: Hepatocyte growth factor (HGF) receptor antagonists are provided. The HGF receptor antagonists include HGF receptor antibodies and fragments thereof. The HGF receptor antagonists can be employed to block binding of HGF to HGF receptors or substantially inhibit HGF receptor activation. The HGF receptor antagonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treating cancer using the HGF receptor antagonists are also provided.
    Type: Application
    Filed: February 4, 2009
    Publication date: June 11, 2009
    Applicant: GENENTECH, INC.
    Inventors: RALPH H. SCHWALL, KELLY H. TABOR
  • Hepatocyte growth factor receptor antagonists and uses thereof
    Publication number: 20030118587
    Abstract: Hepatocyte growth factor (HGF) receptor antagonists are provided. The HGF receptor antagonists include HGF receptor antibodies and fragments thereof. The HGF receptor antagonists can be employed to block binding of HGF to HGF receptors or substantially inhibit HGF receptor activation. The HGF receptor antagonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treating cancer using the HGF receptor antagonist are also provided.
    Type: Application
    Filed: September 3, 2002
    Publication date: June 26, 2003
    Inventors: Ralph H. Schwall, Kelly H. Tabor
  • Hepatocyte growth factor receptor antagonists and uses thereof
    Patent number: 6468529
    Abstract: Hepatocyte growth factor (HGF) receptor antagonists are provided. The HGF receptor antagonists include HGF receptor antibodies and fragments thereof. The HGF receptor antagonists can be employed to block binding of HGF to HGF receptors or substantially inhibit HGF receptor activation. The HGF receptor antagonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treating cancer using the HGF receptor antagonists are also provided.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: October 22, 2002
    Assignee: Genentech, Inc.
    Inventors: Ralph H. Schwall, Kelly H. Tabor
  • Hepatocyte growth factor receptor antagonists and uses thereof
    Publication number: 20020136721
    Abstract: Hepatocyte growth factor (HGF) receptor antagonists are provided. The HGF receptor antagonists include HGF receptor antibodies and fragments thereof. The HGF receptor antagonists can be employed to block binding of HGF to HGF receptors or substantially inhibit HGF receptor activation. The HGF receptor antagonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treating cancer using the HGF receptor antagonists are also provided.
    Type: Application
    Filed: November 29, 2001
    Publication date: September 26, 2002
    Inventors: Ralph H. Schwall, Kelly H. Tabor
  • Hepatocyte growth factor receptor antagonists and uses thereof
    Patent number: 6207152
    Abstract: Hepatocyte growth factor (HGF) receptor antagonists are provided. The HGF receptor antagonists include HGF receptor antibodies and fragments thereof. The HGF receptor antagonists can be employed to block binding of HGF to HGF receptors or substantially inhibit HGF receptor activation. The HGF receptor antagonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treating cancer using the HGF receptor antagonists are also provided.
    Type: Grant
    Filed: February 17, 1998
    Date of Patent: March 27, 2001
    Assignee: Genentech, Inc.
    Inventors: Ralph H. Schwall, Kelly H. Tabor
  • Hepatocyte growth factor receptor agonists and uses thereof
    Patent number: 6099841
    Abstract: Hepatocyte growth factor (HGF) receptor agonists are provided. The HGF receptor agonists include HGF receptor antibodies and fragments thereof. The HGF receptor agonists can be employed to substantially enhance HGF receptor activation. The HGF receptor agonists may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treatment and diagnosis using the HGF receptor agonists are also provided.
    Type: Grant
    Filed: June 27, 1997
    Date of Patent: August 8, 2000
    Assignee: Genentech, Inc.
    Inventors: Kenneth J. Hillan, Ralph H. Schwall, Kelly H. Tabor